322 related articles for article (PubMed ID: 15389583)
21. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
22. Growth factors in mouse mammary cell interactions in vitro.
Miller FR; Bukowski J
Anticancer Res; 1994; 14(5A):2033-8. PubMed ID: 7847846
[TBL] [Abstract][Full Text] [Related]
23. p53 mutations in mouse mammary epithelial cells: instability in culture and discordant selection of mutations in vitro versus in vivo.
Ozbun MA; Medina D; Butel JS
Cell Growth Differ; 1993 Oct; 4(10):811-9. PubMed ID: 8274450
[TBL] [Abstract][Full Text] [Related]
24. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
Seeger H; Rakov V; Mueck AO
Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
[TBL] [Abstract][Full Text] [Related]
25. [Inhibitive effects of mifepristone on growth of breast cancer: experiment with animal model].
Tian XS; Zhou WH; Wu GJ; Sun JZ; Cong MH
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):559-63. PubMed ID: 18649774
[TBL] [Abstract][Full Text] [Related]
26. Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth.
Sartorius CA; Harvell DM; Shen T; Horwitz KB
Cancer Res; 2005 Nov; 65(21):9779-88. PubMed ID: 16266999
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility of human breast epithelial cells in vitro to hormones and drugs.
Calaf GM
Int J Oncol; 2006 Feb; 28(2):285-95. PubMed ID: 16391781
[TBL] [Abstract][Full Text] [Related]
28. Mammary fibroblast influence on normal mouse mammary epithelial cell responses to estrogen in vitro.
Haslam SZ
Cancer Res; 1986 Jan; 46(1):310-6. PubMed ID: 3940197
[TBL] [Abstract][Full Text] [Related]
29. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation.
Gattelli A; Cirio MC; Quaglino A; Schere-Levy C; Martinez N; Binaghi M; Meiss RP; Castilla LH; Kordon EC
Cancer Res; 2004 Aug; 64(15):5193-9. PubMed ID: 15289324
[TBL] [Abstract][Full Text] [Related]
30. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.
Ethier SP; Mahacek ML; Gullick WJ; Frank TS; Weber BL
Cancer Res; 1993 Feb; 53(3):627-35. PubMed ID: 8425198
[TBL] [Abstract][Full Text] [Related]
31. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
32. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro.
Ozbun MA; Jerry DJ; Kittrell FS; Medina D; Butel JS
Cancer Res; 1993 Apr; 53(7):1646-52. PubMed ID: 8453637
[TBL] [Abstract][Full Text] [Related]
33. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression.
Shekhar MP; Werdell J; Santner SJ; Pauley RJ; Tait L
Cancer Res; 2001 Feb; 61(4):1320-6. PubMed ID: 11245428
[TBL] [Abstract][Full Text] [Related]
34. Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors.
Molinolo AA; Lanari C; Charreau EH; Sanjuan N; Pasqualini CD
J Natl Cancer Inst; 1987 Dec; 79(6):1341-50. PubMed ID: 2826865
[TBL] [Abstract][Full Text] [Related]
35. Estrogen induces a systemic growth factor through an estrogen receptor-alpha-dependent mechanism.
Bigsby RM; Caperell-Grant A; Berry N; Nephew K; Lubahn D
Biol Reprod; 2004 Jan; 70(1):178-83. PubMed ID: 13679309
[TBL] [Abstract][Full Text] [Related]
36. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
Seeger H; Wallwiener D; Mueck AO
Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
[TBL] [Abstract][Full Text] [Related]
37. Establishment and characterization of six new human endometrial adenocarcinoma cell lines.
Möbus V; Gerharz CD; Mitze M; Moll R; Pollow K; Kother T; Knapstein PG; Kreienberg R
Gynecol Oncol; 1993 Mar; 48(3):370-83. PubMed ID: 7681807
[TBL] [Abstract][Full Text] [Related]
38. AF5, a CNS cell line immortalized with an N-terminal fragment of SV40 large T: growth, differentiation, genetic stability, and gene expression.
Truckenmiller ME; Vawter MP; Zhang P; Conejero-Goldberg C; Dillon-Carter O; Morales N; Cheadle C; Becker KG; Freed WJ
Exp Neurol; 2002 Jun; 175(2):318-37. PubMed ID: 12061863
[TBL] [Abstract][Full Text] [Related]
39. MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements.
Giulianelli S; Herschkowitz JI; Patel V; Lamb CA; Gutkind JS; Molinolo A; Perou CM; Lanari C
Breast Cancer Res Treat; 2011 Aug; 129(1):49-67. PubMed ID: 20890655
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional profiles of progestogen effects in the postmenopausal breast.
Wood CE; Register TC; Cline JM
Breast Cancer Res Treat; 2009 Mar; 114(2):233-42. PubMed ID: 18404370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
